What is New in Febrile Seizure Management?
The most important recent update is the unequivocal recommendation against any prophylactic anticonvulsant therapy—including newer agents like clobazam—for simple febrile seizures, as the potential toxicities clearly outweigh benefits in this benign condition. 1
Key Updates in Acute Management
Immediate Seizure Control
- For seizures lasting >5 minutes, lorazepam 0.05-0.1 mg/kg IV (maximum 4 mg) given slowly at 2 mg/min is the first-line treatment, with positioning the child on their side and protecting the head from injury. 1, 2
- When IV access is unavailable, rectal diazepam should be administered; IM diazepam is specifically contraindicated due to erratic absorption. 1
- Never restrain the child or place anything in their mouth during active seizure activity. 1, 2
Febrile Status Epilepticus Protocol (New Evidence)
For prolonged febrile seizures evolving into status epilepticus, a structured algorithm has emerged:
- First-line: Lorazepam 0.1 mg/kg IV (maximum 2 mg), repeat once after at least 1 minute if seizures continue. 2
- Second-line: Levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) should be given concurrently with benzodiazepines rather than sequentially, representing a shift from older sequential protocols. 2
- Third-line: Phenobarbital 10-20 mg/kg IV (maximum 1,000 mg) for refractory cases, with continuous EEG monitoring. 2
- Maintenance therapy includes lorazepam 0.05 mg/kg IV every 8 hours for three doses plus levetiracetam 30 mg/kg IV every 12 hours. 2
Prophylactic Management: What NOT to Do
Continuous Prophylaxis
The American Academy of Pediatrics explicitly recommends against both continuous and intermittent anticonvulsant prophylaxis for simple febrile seizures, based on high-quality randomized controlled trials (evidence quality B). 1, 2
This prohibition includes:
- Phenobarbital: Causes hyperactivity, irritability, and mean IQ reduction of 7 points during treatment (persisting 5.2 points lower even 6 months after discontinuation). 2
- Valproic acid: Risk of rare fatal hepatotoxicity, especially in children <2 years, plus thrombocytopenia and pancreatitis. 1, 2
- Clobazam: Despite one trial showing benefit (RR 0.36), this was against an unusually high 83.3% control recurrence rate and requires replication; current guidelines do not support its use. 1, 3
- Carbamazepine and phenytoin: Proven ineffective, with carbamazepine showing 47% recurrence versus 10% with phenobarbital. 2
Intermittent Prophylaxis
- Intermittent diazepam during febrile illnesses may reduce recurrence rates but does not improve long-term outcomes and causes lethargy, drowsiness, and ataxia. 1, 2, 3
- The Cochrane review found reduced recurrence with intermittent diazepam (RR 0.64-0.73 at various time points), but this benefit does not justify routine use given adverse effects in up to 36% of children. 3
- Antipyretics (acetaminophen, ibuprofen) do not prevent febrile seizures or reduce recurrence risk, though they may improve comfort. 1, 2, 4
Diagnostic Evaluation Updates
When NOT to Image or Test
Routine neuroimaging (CT or MRI) is NOT indicated for simple febrile seizures, as the American College of Radiology and American Academy of Pediatrics explicitly state. 1, 2
- Even in complex febrile seizures, imaging abnormalities occur in only 14.8% versus 11.4% in simple seizures, and these findings do not alter clinical management. 1
- Analysis of 161 children with complex febrile seizures showed head CT revealed no findings requiring intervention. 1, 2
- EEG is explicitly listed as an inappropriate investigation that should not be performed on more than a small minority of patients with simple febrile seizures. 2
When to Consider Lumbar Puncture
Children under 12 months of age with fever and seizure should undergo lumbar puncture to rule out meningitis, as meningeal signs may be absent in up to one-third of cases. 2
For well-appearing children >12 months with simple febrile seizures, lumbar puncture is not routinely required except as indicated to identify the source of fever. 2, 4
Prognosis and Parent Education (Evidence-Based Reassurance)
Excellent Long-Term Outcomes
More than 90% of children with febrile seizures will not develop epilepsy, and simple febrile seizures cause no decline in IQ, academic performance, neurocognitive function, or behavioral abnormalities. 1, 2
- The risk of epilepsy by age 7 is approximately 1%, identical to the general population. 2
- Even high-risk children (multiple seizures, age <12 months at first seizure, family history of epilepsy) have only 2.4% risk of epilepsy by age 25. 1, 2
- No evidence exists that simple febrile seizures cause structural brain damage. 2
Recurrence Risk Stratification
- Children <12 months at first seizure: ~50% recurrence probability. 2
- Children >12 months at first seizure: ~30% recurrence probability. 2
- Of those with a second seizure, 50% will have at least one additional recurrence. 2
Critical Pitfalls to Avoid
Inappropriate Medication Prescribing
If a child is already on phenobarbital for simple febrile seizures, the American Academy of Pediatrics recommends tapering and discontinuing it, as it was inappropriately initiated and provides no benefit in preventing epilepsy development. 2
Misdiagnosis Concerns
Staring episodes during fever should trigger evaluation for absence epilepsy or CNS infection rather than being dismissed as febrile seizures, as true febrile seizures are generalized tonic-clonic, not absence-type. 2
Emergency Indications
Activate emergency services for:
- First-time seizures
- Seizures lasting >5 minutes
- Multiple seizures without return to baseline
- Seizures with traumatic injuries, breathing difficulties, or choking 1
Practical Home Management Strategy
The preferred management is parent education and reassurance rather than medication, emphasizing:
- The benign nature and excellent prognosis 1, 2
- Practical first aid: position on side, protect head, clear environment 1
- When to seek emergency care 1
- An attractive alternative is to provide parents with rectal diazepam to administer at home at seizure onset to prevent febrile status epilepticus, though this does not improve long-term outcomes. 5